82 related articles for article (PubMed ID: 3262341)
21. 2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
Johnson MA; Johns DG; Fridland A
Biochem Biophys Res Commun; 1987 Nov; 148(3):1252-8. PubMed ID: 2825680
[TBL] [Abstract][Full Text] [Related]
22. Formation of 3-(2'-deoxyribofuranosyl) and 9-(2'-deoxyribofuranosyl) nucleosides of 8-substituted purines by nucleoside deoxyribosyltransferase.
Huang MC; Montgomery JA; Thorpe MC; Stewart EL; Secrist JA; Blakley RL
Arch Biochem Biophys; 1983 Apr; 222(1):133-44. PubMed ID: 6838216
[TBL] [Abstract][Full Text] [Related]
23. Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro.
Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E; Desmyter J
Antimicrob Agents Chemother; 1987 Oct; 31(10):1613-7. PubMed ID: 3435108
[TBL] [Abstract][Full Text] [Related]
24. Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.
Dahlberg JE; Mitsuya H; Blam SB; Broder S; Aaronson SA
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2469-73. PubMed ID: 3470806
[TBL] [Abstract][Full Text] [Related]
25. Substrate specificity of the purine-2'-deoxyribonucleosidase of Crithidia luciliae.
Steenkamp DJ; Hälbich TJ
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):125-9. PubMed ID: 1417764
[TBL] [Abstract][Full Text] [Related]
26. Development of chemo-enzymatic process and manufacture of deoxynucleosides.
Komatsu H; Awano H; Ishibashi H; Ikeda I
Nucleic Acids Res Suppl; 2001; (1):49-50. PubMed ID: 12836258
[TBL] [Abstract][Full Text] [Related]
27. Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity.
Cooney DA; Ahluwalia G; Mitsuya H; Fridland A; Johnson M; Hao Z; Dalal M; Balzarini J; Broder S; Johns DG
Biochem Pharmacol; 1987 Jun; 36(11):1765-8. PubMed ID: 3107569
[No Abstract] [Full Text] [Related]
28. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
Balzarini J; Pauwels R; Baba M; Robins MJ; Zou RM; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 May; 145(1):269-76. PubMed ID: 3496089
[TBL] [Abstract][Full Text] [Related]
29. Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC column.
Balzarini J; Cools M; De Clercq E
Biochem Biophys Res Commun; 1989 Jan; 158(2):413-22. PubMed ID: 2916990
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis.
Herdewijn P; Pauwels R; Baba M; Balzarini J; De Clercq E
J Med Chem; 1987 Nov; 30(11):2131-7. PubMed ID: 3499515
[TBL] [Abstract][Full Text] [Related]
31. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Richman DD; Kornbluth RS; Carson DA
J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
[TBL] [Abstract][Full Text] [Related]
32. Structures of purine 2'-deoxyribosyltransferase, substrate complexes, and the ribosylated enzyme intermediate at 2.0 A resolution.
Anand R; Kaminski PA; Ealick SE
Biochemistry; 2004 Mar; 43(9):2384-93. PubMed ID: 14992575
[TBL] [Abstract][Full Text] [Related]
33. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
[TBL] [Abstract][Full Text] [Related]
34. Trans-N-deoxyribosylase from Lactobacillus helveticus. Crystallization and properties.
Uerkvitz W
Eur J Biochem; 1971 Nov; 23(2):387-95. PubMed ID: 5156378
[No Abstract] [Full Text] [Related]
35. Uptake of 2',3'-dideoxyadenosine in human immunodeficiency virus-infected and noninfected human cells.
Agarwal RP; Busso ME; Mian AM; Resnick L
AIDS Res Hum Retroviruses; 1989 Oct; 5(5):541-50. PubMed ID: 2590557
[TBL] [Abstract][Full Text] [Related]
36. Functional cloning, heterologous expression, and purification of two different N-deoxyribosyltransferases from Lactobacillus helveticus.
Kaminski PA
J Biol Chem; 2002 Apr; 277(17):14400-7. PubMed ID: 11836245
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
[TBL] [Abstract][Full Text] [Related]
39. 2-halo-2',3'-dideoxyadenosines: metabolically stable dideoxynucleosides with activity against the human immunodeficiency virus (HIV).
Carson DA; Haertle T; Carrera CJ; Willis EH; Wasson DB; Richman DD
Adv Exp Med Biol; 1989; 253B():395-8. PubMed ID: 2610127
[No Abstract] [Full Text] [Related]
40. Restricted transport of 3'-azido-3'-deoxythymidine and dideoxynucleosides through the blood-brain barrier.
Terasaki T; Pardridge WM
J Infect Dis; 1988 Sep; 158(3):630-2. PubMed ID: 2842410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
